Literature DB >> 36087223

Prevalence, Predictors, and Management of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy: a Multicenter Cohort Study.

Ayman El Nakeeb1,2, Hassan Aldossary3, Ahmed Zaid3, Mohamed El Sorogy4, Mohamad Elrefai4, Mohamed Attia4, Alaa Mostafa Sewefy5, Taha Kayed5, Mubarak Al-Shari Aldawsari3, Hathal Mashan Al Dossari3, Mohammed M Mohammed5.   

Abstract

BACKGROUND: One of the most popular bariatric procedures is laparoscopic sleeve gastrectomy (LSG), which can either cause or worsen gastroesophageal reflux disease (GERD). Therefore, the goal of this study was to examine the prevalence, predictors, and management of GERD symptoms after LSG.
MATERIALS AND METHODS: From January 2017 to January 2022, we looked at patients who had a primary LSG and developed GERD. Before LSG, all patients underwent a barium meal and upper endoscopy. After LSG, barium meal, endoscopy, esophageal manometry, and 24-h pH measurements were performed for selected patients. The diagnosis of GERD is based on the GERD-HRQL questionnaire and upper endoscopy.
RESULTS: The study included 1537 patients (62.5% women and 37.5% men) with a mean age of 34.4 years. The mean % TWL was 40.7% during a mean follow-up period of 15.9 months. A total of 379 patients (24.7%) experienced postoperative GERD, of whom 328 (21.3%) had postoperative de novo GERD symptoms, 25 (1.6%) had worsened preoperative GERD, and 26 (1.7%) had the same preoperative GERD symptoms. Antral preservation and gastropexy were protective factors against the development of GERD after LSG. LSG was converted to LRYGB in 15.8% of the patients with GERD. The response to medical treatment was observed in 300 (79.2%) patients with GERD.
CONCLUSION: Post-LSG GERD presented in 379 patients (24.7%). Antral preservation and gastropexy were protective factors for the development of postoperative GERD after LSG. Medical treatment was the main line of treatment for GERD. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT05416645.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Gastroesophageal reflux; Gastropexy; Laparoscopic Roux-en-Y gastric bypass; Laparoscopic sleeve gastrectomy; Morbid obesity

Year:  2022        PMID: 36087223     DOI: 10.1007/s11695-022-06264-w

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


  4 in total

1.  Predictive Factors of Gastroesophageal Reflux Disease in Bariatric Surgery: a Controlled Trial Comparing Sleeve Gastrectomy with Gastric Bypass.

Authors:  Daniel Navarini; Carlos Augusto S Madalosso; Alexandre P Tognon; Fernando Fornari; Fábio R Barão; Richard R Gurski
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

2.  Prevalence and Predictors of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy.

Authors:  Saad Althuwaini; Fahad Bamehriz; Abdullah Aldohayan; Waleed Alshammari; Saleh Alhaidar; Mazen Alotaibi; Abdullah Alanazi; Hossam Alsahabi; Majid Abdularahman Almadi
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

3.  Predictive Factors for Developing GERD After Sleeve Gastrectomy: Is Preoperative Endoscopy Necessary?

Authors:  Omar Bellorin; James C Senturk; Mariana Vigiola Cruz; Gregory Dakin; Cheguevara Afaneh
Journal:  J Gastrointest Surg       Date:  2022-01-08       Impact factor: 3.452

4.  Integrating the Hill's Classification of Gastroesophageal Junction into the Artificial Intelligence Predictive Model for Gastroesophageal Reflux Disease after Sleeve Gastrectomy; a Room for Improvement?

Authors:  Waleed Ghareeb; Sameh Hany Emile
Journal:  Obes Surg       Date:  2022-06-20       Impact factor: 3.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.